Effect of a heart failure clinic on survival and hospital readmission in patients discharged from acute hospital care

European Journal of Heart Failure

Volumn 4, Issue 3, 2002, Pages 353-359

  Azevedo, Ana ^a,b,c   Pimenta, Joana ^a   Dias, Paula ^a   Bettencourt, Paulo ^a,b   Ferreira, António ^a,b   Cerqueira Gomes, Mário ^b  

^a Department of Internal Medicine   (Portugal)

^b Unidade de Investigação e Desenvolvimento Cardiovascular Do Porto   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Heart failure; Outcomes; Outpatient management; Prognosis; Survival

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SODIUM; URIC ACID;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOCTOR PATIENT RELATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SEX RATIO; SODIUM BLOOD LEVEL; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING; URIC ACID BLOOD LEVEL;

AGED; CARDIOLOGY; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALS, SPECIAL; HUMANS; INTERNAL MEDICINE; MALE; PATIENT READMISSION; PRIMARY HEALTH CARE; PROGNOSIS; PROSPECTIVE STUDIES; STATISTICS; SURVIVAL RATE;

EID: 0036623814     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00013-2     Document Type: Article

References (24)

1. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997;18:736-53.
2. Heart Failure Society of America. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches. J Cardiac Fail 1999;5:357-82.
3. Membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999;83:2A-38A.
4. Torp-Pedersen C, Kober L. Prolongation of life with angiotensin-converting enzyme inhibitor therapy. Eur Heart J 2000;21:597-8.
5. Pitt B, Nicklas JM. Specialized heart failure centers - a success or an indicator of the failure of our healthcare delivery system. Clin Cardiol 2000;23:881-2.
6. Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation 1997;96:2755-7. Editorial.
7. Rajfer SI. Perspective of the pharmaceutical industry on the development of new drugs for heart failure. J Am Coll Cardiol 1993;22(Suppl A):198-200.
8. Philbin EF, Andreou C, Rocco T, Lunch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832-8.
9. Smith NL, Psaty BM, Pitt B, Garg R, Gottdiener JS, Heckbert SR. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995. Arch Intern Med 1998;158:1074-80.
10. Rich MW. Heart failure disease management: a critical review. J Cardiac Fail 1999;5:64-75.
11. Ramahi TM, Longo MD, Rohlfs K, Sheynberg N. Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure. Clin Cardiol 2000;23:909-14.
12. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30:725-32.
13. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.
14. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-51.
15. Bettencourt P, Ferreira A, Dias P, et al. Predictors of prognosis in patients with stable mild to moderate heart failure. J Cardiac Fail 2000;6:306-13.
16. Bucknall CE, Robertson C, Moran F, Stevenson RD. Differences in hospital asthma management. Lancet 1988;1:748-50.
17. Mayo PH, Richman J, Harris HW. Results of a program to reduce admissions for adult asthma. Ann Intern Med 1990;112:801-2.
18. Ward MM, Leigh JP, Fries JF. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. Arch Intern Med 1993;153:2229-37.
19. Smith LE, Fabbri AS, Pai R, Ferry D, Heywood T. Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic. Clin Cardiol 1997;20:949-54.
20. Jaagosild P, Dawson NV, Thomas C, et al. Outcomes of acute exacerbation of severe congestive heart failure. Arch Intern Med 1998;158:1081-9.
21. Cowie MR, Wood DA, Coats AJS, et al. Survival of patients with a new diagnosis of heart failure: a population-based study. Heart 2000;83:505-10.
22. Hanumanthu S, Butler J, Chomsky D, Davis S, Wilson JR. Effect of a heart failure program on hospitalization frequency and exercise tolerance. Circulation 1997;96:2842-8.
23. Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-710.
24. Cline CM, Israelsson BY, Willenheimer RB, Broms K, Erhardt LR. Cost-effective management programme for heart failure reduces hospitalisation. Heart 1998;80:442-6.